Cargando…
A Comprehensive Comparison of the Continual Reassessment Method to the Standard 3 + 3 Dose Escalation Scheme in Phase I Dose-Finding Studies
BACKGROUND: An extensive literature has covered the statistical properties of the Continual Reassessment Method (CRM) and the modifications of this method. While there are some applications of CRM designs in recent Phase I trials, the standard method (SM) of escalating doses after three patients wit...
Autores principales: | Iasonos, Alexia, Wilton, Andrew S, Riedel, Elyn R, Seshan, Venkatraman E, Spriggs, David R |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2637378/ https://www.ncbi.nlm.nih.gov/pubmed/18827039 http://dx.doi.org/10.1177/1740774508096474 |
Ejemplares similares
-
Dose Finding by the Continual Reassessment Method
por: Cheung, Ying
Publicado: (2011) -
Phase I dose escalation safety and feasibility study of autologous WT1-sensitized T cells for the treatment of patients with recurrent ovarian cancer
por: Kyi, Chrisann, et al.
Publicado: (2021) -
A new pragmatic design for dose escalation in phase 1 clinical trials using an adaptive continual reassessment method
por: North, Bernard, et al.
Publicado: (2019) -
Continual reassessment method for dose escalation clinical trials in oncology: a comparison of prior skeleton approaches using AZD3514 data
por: James, Gareth D., et al.
Publicado: (2016) -
Assessment of various continual reassessment method models for dose-escalation phase 1 oncology clinical trials: using real clinical data and simulation studies
por: James, G. D., et al.
Publicado: (2021)